Metraipolis › archive › dc_5f1a29d390db
Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42794978
- DOI
- 10.3390/cancers18183011
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-09T06:27:02.153Z
- SHA-256 of the archived text
010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d- Stable URL of this page
https://metraipolis.com/documento/dc_5f1a29d390db
How to cite
Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978 — Europe PMC (en), https://europepmc.org/article/MED/42794978 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f1a29d390db (Metraipolis archive dc_5f1a29d390db, sha256 010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d)
BibTeX
@misc{dc5f1a29d390db,
title = {Erythropoietin in Tumor Immunity: Mechanistic Evidence, Clinical Cautions, and Translational Opportunities — Europe PMC PMID:42794978},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42794978},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f1a29d390db; sha256 010bec8d13321fbba4552adc545dce14f79c7184bda3378af583e7fe54768b5d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794978. Agents can read the archived copy with the MCP tool read_document.